| http://www.w3.org/ns/prov#value | - These changes were brought about as the result of a stock purchase agreement changing majority ownership of the company. ???Dr. Sablin, who has a track record of excellence in drug discovery and development, is a founder of Selena Pharmaceuticals and a co-founder of Medivation, companies that advanced Dimebon, a Phase III technology that resulted in a deal with Pfizer with an over $200 million in
|
